$NEPH
Nephros Inc.
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$4.31
▲+1.89%+$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNephros Inc.
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is NEPH up today? It is at $4.31 (+1.89%). See the catalyst behind the move, real-time alerts the moment NEPH spikes, and full due diligence on NEPH — key stats, earnings, dilution and insider activity. Free.
Be first to know when $NEPH makes an unusual move. Create a free account to track $NEPH, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NEPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NEPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Amron Arthur H Director | Acquired (grant/award) | +18K 0.2% of company | added 13% | 159K | n/a | Sep 14, 26 |
Amron Arthur H Director | Acquired (grant/award) | +26K 0.2% of company | n/a | 26K | n/a | Sep 14, 26 |
Wexford Capital Lp Beneficial Owner (10%) | Sold (automatic/other) | -3.38M 31.1% of company | sold 95% | 167K | n/a | Sep 14, 26 |
Wexford Capital Lp Beneficial Owner (10%) | Other | 812 | added 1.4% | 57K | $3K at $3.60 | Aug 18, 26 |
Amron Arthur H Director | Acquired (grant/award) | +2K 0.02% of company | added 1.7% | 141K | n/a | Aug 12, 26 |
Amron Arthur H Director | Acquired (grant/award) | +4K 0.03% of company | added 2.6% | 138K | n/a | May 11, 26 |
Krandel Judy Officer | Other | 69K 0.6% of company | n/a | 69K | $118K at $1.71 | Mar 23, 26 |
Banks Robert R. Jr. Officer | Other | 120K 1.1% of company | added 100% | 190K | $173K at $1.44 | Mar 23, 26 |
Amron Arthur H Director | Acquired (grant/award) | +4K 0.03% of company | added 2.8% | 135K | n/a | Mar 16, 26 |
Amron Arthur H Director | Acquired (grant/award) | +5K 0.05% of company | added 4.3% | 131K | n/a | Nov 10, 25 |
Spandow Oliver J. Director | Acquired (grant/award) | +8K 0.07% of company | added 7.0% | 123K | n/a | Nov 10, 25 |
Nettis Lisa Marie Director | Acquired (grant/award) | +2K 0.01% of company | n/a | 2K | n/a | Nov 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on NEPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NEPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NEPH last traded at $4.31, up 1.89% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nephros Inc. (NEPH) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NEPH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NEPH 0 times in the last 30 days.
NEPH (Nephros Inc.) trades on XNAS, with a market cap of about $47M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NEPH for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NEPH discussion
Sign in to ask a question or join the discussion.